Found 7318 matches for
The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
31 August 2021
Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.
23 July 2021
Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.
5 July 2021
NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.
17 June 2021
A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.
9 June 2021
In a record breaking year for the Postgrad Awards 2021, DPhil student Tolu Awoyemi wins PhD Student of the Year. The award recognises the individual PhD student who has become an excellent and inquisitive researcher, who is an integral part of their research group, someone who encourages and supports more junior members of the team, and works alongside the research community more widely.
8 June 2021
The Pfizer Maternal C-19 Vaccine Trial has launched at Oxford University Hospitals NHS Foundation Trust for women between 24-34 weeks pregnant. The Nuffield Department of Women’s & Reproductive Health’s team of doctors, research midwives and nurses are delivering this critical trial to evaluate the safety, tolerability, and immunogenicity of the Pfizer vaccine in pregnant women.
14 May 2021
Further research into the relationship between brittle bones and women's heart disease risk could be beneficial suggest Drs Dexter Canoy and Kazem Rahimi at the Nuffield Dept of Women's & Reproductive Health.
29 April 2021
The world's most comprehensive study of 345,000 people from 48 randomised clinical trials which revealed blood pressure-lowering medication is effective in adults, regardless of starting blood pressure level, is published in The Lancet.
22 April 2021
A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.
30 March 2021
Listen now to the first episode ‘Unheard of – The hidden voice of Endometriosis.’ A bold new podcast series co-hosted by DPhil students Danielle Perro and Magda Mareckova, it seeks answers to the biggest questions posed by the Endometriosis community.
30 March 2021
A world leading study involving over 260,000 participants has sought to resolve the long debated issue about whether using antihypertensive medication heightens the chance of developing cancer.
12 March 2021
Professor Cecilia Lindgren (Prof of Genomic Endocrinology & Metabolism at the Nuffield Dept of Women's & Reproductive Health) has been appointed as the new Director of the University of Oxford’s Big Data Institute.
8 March 2021
100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution.
24 February 2021
The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.
1 February 2021
A collaboration between Prof Ahmed's group at the Nuffield Dept of Women's & Reproductive Health and Dr Chunxiao Song’s lab at the Ludwig Institute for Cancer Research, has established new sequencing methods for distinguishing DNA modifications. The paper: "Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution" has been published in Nature Communications.
19 January 2021
Nature’s SAFE, Europe’s first Living Biobank dedicated to preserving endangered animals has been launched with the mission to save animals from extinction, by harnessing regeneration and reproductive technologies developed via domestic animal breeding.
15 January 2021
The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.
14 January 2021
A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.
16 December 2020
Celebrating the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.